Adi Turjeman , Genady Drozdinsky , Leonard Leibovici
{"title":"The impact of the COVID-19 pandemic on influenza vaccination: A multi-year interrupted time series analysis","authors":"Adi Turjeman , Genady Drozdinsky , Leonard Leibovici","doi":"10.1016/j.ijid.2025.108015","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To assess temporal changes in influenza vaccination coverage and evaluate differences by age and gender in the context of the COVID-19 pandemic.</div></div><div><h3>Methods</h3><div>We conducted a population-based interrupted time series analysis using data from Clalit Health Services in Israel. Adults aged ≥21 years were followed over 11 influenza seasons (2014-2015 to 2024-2025). Annual vaccination rates were stratified by age group (21-40, 41-64, ≥65) and gender. Segmented linear regression assessed changes before and after the pandemic onset. Counterfactual modeling estimated expected vaccination rates in the absence of the pandemic.</div></div><div><h3>Results</h3><div>Vaccination coverage declined from 26.2% (2014-2015) to 17.7% (2024-2025), despite a temporary rise to 28.7% in 2020-2021. Post-pandemic, rates decreased by 2.3 percentage points annually (<em>p</em> = 0.0013). The most pronounced drop was among adults aged ≥65, from 64.8% to 49.2%. Declines were observed across all age and gender groups. Interaction models showed no significant gender differences, but greater declines with increasing age. Counterfactual analysis estimated that 2024-2025 coverage was 5.7 percentage points lower than expected.</div></div><div><h3>Conclusions</h3><div>The COVID-19 pandemic was associated with a sustained decline in influenza vaccination uptake. Targeted strategies are needed to rebuild trust and restore routine immunization, especially among older adults.</div></div>","PeriodicalId":14006,"journal":{"name":"International Journal of Infectious Diseases","volume":"159 ","pages":"Article 108015"},"PeriodicalIF":4.3000,"publicationDate":"2025-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1201971225002395","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To assess temporal changes in influenza vaccination coverage and evaluate differences by age and gender in the context of the COVID-19 pandemic.
Methods
We conducted a population-based interrupted time series analysis using data from Clalit Health Services in Israel. Adults aged ≥21 years were followed over 11 influenza seasons (2014-2015 to 2024-2025). Annual vaccination rates were stratified by age group (21-40, 41-64, ≥65) and gender. Segmented linear regression assessed changes before and after the pandemic onset. Counterfactual modeling estimated expected vaccination rates in the absence of the pandemic.
Results
Vaccination coverage declined from 26.2% (2014-2015) to 17.7% (2024-2025), despite a temporary rise to 28.7% in 2020-2021. Post-pandemic, rates decreased by 2.3 percentage points annually (p = 0.0013). The most pronounced drop was among adults aged ≥65, from 64.8% to 49.2%. Declines were observed across all age and gender groups. Interaction models showed no significant gender differences, but greater declines with increasing age. Counterfactual analysis estimated that 2024-2025 coverage was 5.7 percentage points lower than expected.
Conclusions
The COVID-19 pandemic was associated with a sustained decline in influenza vaccination uptake. Targeted strategies are needed to rebuild trust and restore routine immunization, especially among older adults.
期刊介绍:
International Journal of Infectious Diseases (IJID)
Publisher: International Society for Infectious Diseases
Publication Frequency: Monthly
Type: Peer-reviewed, Open Access
Scope:
Publishes original clinical and laboratory-based research.
Reports clinical trials, reviews, and some case reports.
Focuses on epidemiology, clinical diagnosis, treatment, and control of infectious diseases.
Emphasizes diseases common in under-resourced countries.